Emory University Hospital is a 733-bed facility in Atlanta, Georgia, specializing in the care of acutely ill adults. Emory University Hospital is staffed exclusively by Emory University School of Medicine faculty who also are members of The Emory Clinic.

During the past decade, Emory Healthcare conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 10 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 7 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory Healthcare" #1 sponsor was "Emory University" with 8 trials, followed by "Actelion" with 3 trials sponsored, "Dana-Farber Cancer Institute" with 2 trials sponsored, "Marinus Pharmaceuticals" with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory Healthcare" #1 collaborator was "Emory Healthcare" with 3 trials as a collaborator, "Johns Hopkins University" with 3 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 2 trials as a collaborator, "Emory University" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Emory Healthcare" are "Emphysema" (3 trials), "Prostate Cancer" (3 trials), "Covid19" (2 trials), "Heart Failure" (2 trials) and "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Emory Healthcare" in a lesser frequency.

Most popular intervention types in "Emory Healthcare" are "Drug" (17 trials), "Other" (12 trials), "Device" (10 trials), "Behavioral" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "2D FFDM" (1 trials), "3Dimensional Mammography" (1 trials), "6-minutes walk performance" (1 trials) and "AXIOS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emory Healthcare" are 38 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Emory Healthcare". undefined are not yet recruiting, 12 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 20 completed trials in Emory Healthcare, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Emory Healthcare, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".